SOM Biotech attended the FDA Workshop “Repurposing Off-Patent Drugs: Research & Regulatory Challenge” on December 5th -6th– in Rockville, USA.

The workshop aimed at exploring opportunities and challenges in assessing the safety and efficacy of repurposed drugs, as well as exploring several drug development pathways for treatments, with a specific focus on orphan diseases.

Núria Reig – CSO of SOM Biotech – participated in the interactive sessions to explore different regulatory pathways for drug development, that “helped us to better understand the key aspects to take into consideration to increase the success of our drug re-innovation efforts. As we use new tools and technologies to accelerate the discovery process for repurposing drugs, we understand that enhanced coordination with the regulatory entities is appropriate to further optimize the portfolio and timing of our drug development activities with the ultimate goal of bringing more therapies to market and change the lives of patients for the better”.

Leave a Reply

Your email address will not be published. Required fields are marked *